103 related articles for article (PubMed ID: 124097)
1. Single donor, HL-A matched platelet transfusions for thrombocytopenic patients undergoing surgery.
Kahan BD; Green D; Ruder A; Ranney DF; Hartz WH; Mittal KK
Surgery; 1975 Feb; 77(2):241-8. PubMed ID: 124097
[TBL] [Abstract][Full Text] [Related]
2. HL-A matching in thrombocyte and leukocyte transfusions.
Matej H; Olearczyk J; Partyka T; Kotlarek-Haus S; Stawarz M; Dzierzkowa-Borodej W
Arch Immunol Ther Exp (Warsz); 1975; 23(2):181-7. PubMed ID: 807177
[TBL] [Abstract][Full Text] [Related]
3. Matching of histocompatibility (HL-A) antigens for platelet transfusion.
Mittal KK; Ruder EA; Green D
Blood; 1976 Jan; 47(1):31-41. PubMed ID: 1244913
[TBL] [Abstract][Full Text] [Related]
4. Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates.
Herzig RH; Herzig GP; Bull MI; Decter JA; Lohrmann HP; Stout FG; Yankee RA; Graw RG
Blood; 1975 Nov; 46(5):743-50. PubMed ID: 1174708
[TBL] [Abstract][Full Text] [Related]
5. [Substitution ofpolysensitized patients with platelets from HL-A typed single donors].
Gmür J; Baumberger U; von Felten A
Schweiz Med Wochenschr; 1976 Oct; 106(40):1358-9. PubMed ID: 1006253
[TBL] [Abstract][Full Text] [Related]
6. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
Levy L; Woodfield DG
N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
[TBL] [Abstract][Full Text] [Related]
7. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
Basire A; Picard C
Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
[TBL] [Abstract][Full Text] [Related]
8. Use of platelet aggregometry in selection of compatible platelet donors.
Wu KK; Hoak JC; Thompson JS; Koepke JA
N Engl J Med; 1975 Jan; 292(3):130-3. PubMed ID: 1196337
[TBL] [Abstract][Full Text] [Related]
9. Platelet transfusions: shortened survival of HL-A-identical platelets and failure of in vitro detection of anti-platelet antibodies after multiple transfusions.
Bucher U; de Weck A; Spengler H; Tschopp L; Kummer H
Vox Sang; 1973; 25(2):187-92. PubMed ID: 4737547
[No Abstract] [Full Text] [Related]
10. Cytotoxic antibody complicating platelet support in acute leukemia. Response to chemotherapy.
Green D; Tiro A; Basiliere J; Mittal KK
JAMA; 1976 Aug; 236(9):1044-6. PubMed ID: 1067454
[TBL] [Abstract][Full Text] [Related]
11. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
Claas FH; Smeenk RJ; Schmidt R; van Steenbrugge GJ; Eernisse JG
Exp Hematol; 1981 Jan; 9(1):84-9. PubMed ID: 7238645
[TBL] [Abstract][Full Text] [Related]
12. Repeated platelet transfusions from HL-A compatible unrelated and sibling donors.
Thorsby E; Helgesen A; Gjemdal T
Tissue Antigens; 1972; 2(5):397-404. PubMed ID: 4266154
[No Abstract] [Full Text] [Related]
13. Heterogeneity of antibody response to human platelet transfusion.
Wu KK; Thompson JS; Koepke JA; Hoak JC; Flink R
J Clin Invest; 1976 Aug; 58(2):432-8. PubMed ID: 956376
[TBL] [Abstract][Full Text] [Related]
14. Typing for the MLC determinants and its possible impact on Europdonor.
van Rood JJ; van Leeuwen A; van den Tweel JG; Blussé van Oud Alblas A; Keuning JJ; Eernisse JG
Transplant Proc; 1974 Dec; 6(4):411-5. PubMed ID: 4140594
[No Abstract] [Full Text] [Related]
15. Selection of compatible platelet donors: a prospective evaluation of three cross-matching techniques.
Wu KK; Hoak JC; Koepke JA; Thompson JS
Transfusion; 1977; 17(6):638-43. PubMed ID: 145673
[TBL] [Abstract][Full Text] [Related]
16. Antileukocyte antibodies in patients refractory to platelet transfusions.
MacPherson BR; Westphal RG
Am J Clin Pathol; 1979 Dec; 72(6):893-7. PubMed ID: 517458
[TBL] [Abstract][Full Text] [Related]
17. [Human leukocyte antigen system (HL-A)].
Juji T
Rinsho Byori; 1973 Jan; 21(1):59-64. PubMed ID: 4267651
[No Abstract] [Full Text] [Related]
18. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duqesnoy RJ
Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
[No Abstract] [Full Text] [Related]
19. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum.
Weiden PL; Storb R; Slichter S; Warren RP; Sale GE
J Immunol; 1976 Jul; 117(1):143-50. PubMed ID: 6593
[TBL] [Abstract][Full Text] [Related]
20. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence tests.
Brand A; van Leeuwen A; Eernisse JG; van Rood JJ
Blood; 1978 May; 51(5):781-8. PubMed ID: 346088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
